127 related articles for article (PubMed ID: 11950491)
1. Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Palomba S; Sena T; Morelli M; Noia R; Zullo F; Mastrantonio P
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):199-201. PubMed ID: 11950491
[TBL] [Abstract][Full Text] [Related]
2. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas.
Palomba S; Sena T; Noia R; Di Carlo C; Zullo F; Mastrantonio P
Obstet Gynecol; 2001 Dec; 98(6):1053-8. PubMed ID: 11755553
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
[No Abstract] [Full Text] [Related]
4. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.
Palomba S; Sammartino A; Di Carlo C; Affinito P; Zullo F; Nappi C
Fertil Steril; 2001 Jul; 76(1):38-43. PubMed ID: 11438317
[TBL] [Abstract][Full Text] [Related]
5. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Sener AB; Seçkin NC; Ozmen S; Gökmen O; Doğu N; Ekici E
Fertil Steril; 1996 Feb; 65(2):354-7. PubMed ID: 8566261
[TBL] [Abstract][Full Text] [Related]
6. Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
Polatti F; Viazzo F; Colleoni R; Nappi RE
Maturitas; 2000 Nov; 37(1):27-32. PubMed ID: 11099870
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
Yang CH; Lee JN; Hsu SC; Kuo CH; Tsai EM
Maturitas; 2002 Sep; 43(1):35-9. PubMed ID: 12270580
[TBL] [Abstract][Full Text] [Related]
8. Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
Ylöstalo P; Granberg S; Bäckström AC; Hirsjärvi-Lahti T
Maturitas; 1996 Apr; 23(3):313-7. PubMed ID: 8794426
[TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
de Aloysio D; Altieri P; Penacchioni P; Salgarello M; Ventura V
Maturitas; 1998 Jun; 29(3):261-4. PubMed ID: 9699198
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
Fedele L; Bianchi S; Raffaelli R; Zanconato G
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
[TBL] [Abstract][Full Text] [Related]
11. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
12. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Simsek T; Karakus C; Trak B
Maturitas; 2002 Jul; 42(3):243-6. PubMed ID: 12161049
[TBL] [Abstract][Full Text] [Related]
13. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB).
Lasmar RB; Lasmar BP
Best Pract Res Clin Obstet Gynaecol; 2017 Apr; 40():82-88. PubMed ID: 27784616
[TBL] [Abstract][Full Text] [Related]
14. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
15. Bleeding patterns during continuous estradiol with different sequential progestogens therapy.
Di Carlo C; Sammartino A; Di Spiezio Sardo A; Tommaselli GA; Guida M; Mandato VD; D'Elia A; Nappi C
Menopause; 2005; 12(5):520-5. PubMed ID: 16145305
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Lombardi G; Cimini V; Zullo F
Fertil Steril; 2005 Jul; 84(1):154-61. PubMed ID: 16009171
[TBL] [Abstract][Full Text] [Related]
17. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
Sun A; Lin S; Wei Y
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
[TBL] [Abstract][Full Text] [Related]
18. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
19. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
Scialli AR; Jestila KJ
Fertil Steril; 1995 Aug; 64(2):313-20. PubMed ID: 7615109
[TBL] [Abstract][Full Text] [Related]
20. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
